Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: Results from the EPIC II study

International Journal of Antimicrobial Agents

Volumn 38, Issue 4, 2011, Pages 331-335

  Hanberger, Hkan ^a   Walther, Sten ^a   Leone, Marc ^b   Barie, Philip S ^c   Rello, Jordi ^d   Lipman, Jeffrey ^e   Marshall, John C ^f   Anzueto, Antonio ^g   Sakr, Yasser ^h   Pickkers, Peter ⁱ   Felleiter, Peter ^j   Engoren, Milo ^k   Vincent, Jean Louis ^l  

^a LINKÖPING UNIVERSITY   (Sweden)

^b HÔPITAL NORD   (France)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j SWISS PARAPLEGIC RESEARCH   (Switzerland)

^k ST VINCENT MERCY MEDICAL CENTER   (United States)

^l ERASME HOSPITAL   (Belgium)

more..

Author keywords

Antimicrobial resistance; Critically ill; Mortality; Sepsis

Indexed keywords

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SENSITIVE STAPHYLOCOCCUS INFECTION; MORTALITY; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMOFILTRATION; HOSPITAL MORTALITY; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RENAL DIALYSIS; RESPIRATION, ARTIFICIAL; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80052262626     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.05.013     Document Type: Article

References (30)

1. R. Kock, K. Becker, B. Cookson, J. Gemert-Pijnen, S. Harbarth, and J. Kluytmans Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe Euro Surveill 15 2010 19688
2. M. Whitby, M.L. McLaws, and G. Berry Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis Med J Aust 175 2001 264 267 (Pubitemid 32851061)
3. S.I. Blot, K.H. Vandewoude, E.A. Hoste, and F.A. Colardyn Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus Arch Intern Med 162 2002 2229 2235 (Pubitemid 35231593)
4. S.E. Cosgrove, G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis Clin Infect Dis 36 2003 53 59 (Pubitemid 36099097)
5. J.J. Engemann, Y. Carmeli, S.E. Cosgrove, V.G. Fowler, M.Z. Bronstein, and S.L. Trivette Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection Clin Infect Dis 36 2003 592 598 (Pubitemid 36259564)
6. M. Patel, J.D. Weinheimer, K.B. Waites, and J.W. Baddley Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a Veterans Affairs Medical Center Infect Control Hosp Epidemiol 29 2008 503 509 (Pubitemid 351918028)
7. C.I. Kang, J.H. Song, D.R. Chung, K.R. Peck, K.S. Ko, and J.S. Yeom Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort J Infect 61 2010 299 306
8. E.M. Graffunder, and R.A. Venezia Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials J Antimicrob Chemother 49 2002 999 1005 (Pubitemid 34692894)
9. S.E. Cosgrove, Y. Qi, K.S. Kaye, S. Harbarth, A.W. Karchmer, and Y. Carmeli The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges Infect Control Hosp Epidemiol 26 2005 166 174 (Pubitemid 40445022)
10. D. Peres-Bota, H. Rodriguez, G. Dimopoulos, A. DaRos, C. Melot, and M.J. Struelens Are infections due to resistant pathogens associated with a worse outcome in critically ill patients? J Infect 47 2003 307 316 (Pubitemid 37322050)
11. C.A. DeRyke, T.P. Lodise Jr., M.J. Rybak, and P.S. McKinnon Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia Chest 128 2005 1414 1422 (Pubitemid 41324426)
12. J.L. Wang, S.Y. Chen, J.T. Wang, G.H. Wu, W.C. Chiang, and P.R. Hsueh Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus Clin Infect Dis 46 2008 799 806 (Pubitemid 351417178)
13. D.G. Healy, E. Duignan, M. Tolan, V.K. Young, B. O'Connell, and E. McGovern Should cardiac surgery be delayed among carriers of methicillin-resistant Staphylococcus aureus to reduce methicillin-resistant Staphylococcus aureus-related morbidity by preoperative decolonisation? Eur J Cardiothorac Surg 39 2011 68 74
14. A.F. Shorr, N. Haque, C. Taneja, M. Zervos, L. Lamerato, and S. Kothari Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia J Clin Microbiol 48 2010 3258 3262
15. C. Taneja, N. Haque, G. Oster, A.F. Shorr, S. Zilber, and P.O. Kyan Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia J Hosp Med 5 2010 528 534
16. J.L. Vincent, J. Rello, J. Marshall, E. Silva, A. Anzueto, and C.D. Martin International study of the prevalence and outcomes of infection in intensive care units JAMA 302 2009 2323 2329
17. T. Calandra, and J. Cohen The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit Crit Care Med 33 2005 1538 1548 (Pubitemid 40980610)
18. T.R. Fritsche, H.S. Sader, and R.N. Jones Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006) Diagn Microbiol Infect Dis 61 2008 86 95 (Pubitemid 351509753)
19. G.G. Zhanel, M. Decorby, K.A. Nichol, P.J. Baudry, J.A. Karlowsky, and P.R. Lagace-Wiens Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum β-lactamase-producing Escherichia coli in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006) Can J Infect Dis Med Microbiol 19 2008 243 249
20. N.Z. Haque, L.C. Zuniga, P. Peyrani, K. Reyes, L. Lamerato, and C.L. Moore Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia Chest 138 2010 1356 1362
21. J.L. Wang, J.T. Wang, W.H. Sheng, Y.C. Chen, and S.C. Chang Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method BMC Infect Dis 10 2010 159
22. Y. Takesue, K. Nakajima, Y. Takahashi, K. Ichiki, M. Ishihara, and Y. Wada Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia J Infect Chemother 17 2011 52 57
23. T.P. Lodise, P.S. McKinnon, L. Swiderski, and M.J. Rybak Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia Clin Infect Dis 36 2003 1418 1423 (Pubitemid 36702876)
24. G.E. Schramm, J.A. Johnson, J.A. Doherty, S.T. Micek, and M.H. Kollef Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment Crit Care Med 34 2006 2069 2074 (Pubitemid 44305607)
25. W. Sligl, G. Taylor, R.N. Gibney, R. Rennie, and L. Chui Methicillin-resistant Staphylococcus aureus in a Canadian Intensive Care Unit: delays in initiating effective therapy due to the low prevalence of infection Can J Infect Dis Med Microbiol 18 2007 139 143 (Pubitemid 46909970)
26. J. Rodriguez-Bano, A.B. Millan, M.A. Dominguez, C. Borraz, M.P. Gonzalez, and B. Almirante Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus J Infect 58 2009 131 137
27. A. Kumar, P. Ellis, Y. Arabi, D. Roberts, B. Light, and J.E. Parrillo Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock Chest 136 2009 1237 1248
28. D. Marchaim, K.S. Kaye, V.G. Fowler, D.J. Anderson, V. Chawla, and Y. Golan Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia Clin Microbiol Infect 16 2010 747 752
29. C. Giuliano, K.K. Haase, and R. Hall Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections Expert Rev Anti Infect Ther 8 2010 95 106
30. C. Martinez-Capolino, K. Reyes, L. Johnson, J. Sullivan, L. Samuel, and B. Digiovine Impact of active surveillance on meticillin-resistant Staphylococcus aureus transmission and hospital resource utilisation J Hosp Infect 74 2010 232 237